Annual Net Income
-$214.53 M
-$50.61 M-30.88%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual net profit is currently -$214.53 million, with the most recent change of -$50.61 million (-30.88%) on 31 December 2023. During the last 3 years, it has fallen by -$106.89 million (-99.30%). CRNX annual net income is now -3464.20% below its all-time high of -$6.02 million, reached on 31 December 2016.CRNX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$76.83 M
-$2.77 M-3.74%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly net profit is currently -$76.83 million, with the most recent change of -$2.77 million (-3.74%) on 30 September 2024. Over the past year, it has dropped by -$16.73 million (-27.84%). CRNX quarterly net income is now -4561.89% below its all-time high of -$1.65 million, reached on 30 June 2017.CRNX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$277.91 M
-$19.37 M-7.49%
30 September 2024
Summary:
Crinetics Pharmaceuticals TTM net profit is currently -$277.91 million, with the most recent change of -$19.37 million (-7.49%) on 30 September 2024. Over the past year, it has dropped by -$63.38 million (-29.54%). CRNX TTM net income is now -10564.24% below its all-time high of -$2.61 million, reached on 31 March 2017.CRNX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -27.8% | -29.5% |
| 3 y3 years | -99.3% | -149.5% | -158.2% |
| 5 y5 years | -325.5% | -428.1% | -451.2% |
CRNX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.3% | at low | -149.5% | at low | -158.2% | at low |
| 5 y | 5 years | -325.5% | at low | -428.1% | at low | -451.2% | at low |
| alltime | all time | -3464.2% | at low | -4561.9% | at low | <-9999.0% | at low |
Crinetics Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$76.83 M(+3.7%) | -$277.91 M(+7.5%) |
| June 2024 | - | -$74.06 M(+10.6%) | -$258.54 M(+9.8%) |
| Mar 2024 | - | -$66.93 M(+11.4%) | -$235.46 M(+9.8%) |
| Dec 2023 | -$214.53 M(+30.9%) | -$60.10 M(+4.6%) | -$214.53 M(+7.6%) |
| Sept 2023 | - | -$57.46 M(+12.7%) | -$199.42 M(+8.4%) |
| June 2023 | - | -$50.98 M(+10.8%) | -$183.89 M(+4.9%) |
| Mar 2023 | - | -$45.99 M(+2.2%) | -$175.29 M(+6.9%) |
| Dec 2022 | -$163.92 M(+52.3%) | -$44.99 M(+7.3%) | -$163.92 M(+9.5%) |
| Sept 2022 | - | -$41.92 M(-1.1%) | -$149.72 M(+10.4%) |
| June 2022 | - | -$42.38 M(+22.4%) | -$135.65 M(+13.6%) |
| Mar 2022 | - | -$34.63 M(+12.4%) | -$119.37 M(+10.9%) |
| Dec 2021 | -$107.64 M(+45.8%) | -$30.79 M(+10.6%) | -$107.64 M(+9.3%) |
| Sept 2021 | - | -$27.85 M(+6.7%) | -$98.49 M(+10.7%) |
| June 2021 | - | -$26.09 M(+13.9%) | -$88.96 M(+12.1%) |
| Mar 2021 | - | -$22.90 M(+5.8%) | -$79.35 M(+7.5%) |
| Dec 2020 | -$73.81 M | -$21.64 M(+18.1%) | -$73.81 M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$18.32 M(+11.1%) | -$66.72 M(+6.2%) |
| June 2020 | - | -$16.49 M(-5.0%) | -$62.83 M(+6.9%) |
| Mar 2020 | - | -$17.36 M(+19.3%) | -$58.77 M(+16.5%) |
| Dec 2019 | -$50.42 M(+86.0%) | -$14.55 M(+0.8%) | -$50.42 M(+13.6%) |
| Sept 2019 | - | -$14.43 M(+16.1%) | -$44.37 M(+18.2%) |
| June 2019 | - | -$12.43 M(+37.8%) | -$37.53 M(+22.4%) |
| Mar 2019 | - | -$9.02 M(+6.1%) | -$30.67 M(+13.1%) |
| Dec 2018 | -$27.11 M(+196.1%) | -$8.49 M(+12.0%) | -$27.11 M(+28.3%) |
| Sept 2018 | - | -$7.59 M(+36.3%) | -$21.14 M(+32.7%) |
| June 2018 | - | -$5.57 M(+1.9%) | -$15.94 M(+32.6%) |
| Mar 2018 | - | -$5.46 M(+116.7%) | -$12.02 M(+31.2%) |
| Dec 2017 | -$9.16 M(+52.1%) | -$2.52 M(+5.8%) | -$9.16 M(+38.0%) |
| Sept 2017 | - | -$2.38 M(+44.5%) | -$6.64 M(+56.0%) |
| June 2017 | - | -$1.65 M(-36.8%) | -$4.25 M(+63.2%) |
| Mar 2017 | - | -$2.61 M | -$2.61 M |
| Dec 2016 | -$6.02 M | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual net profit?
- What is the all time high annual net income for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly net income year-on-year change?
- What is Crinetics Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM net income year-on-year change?
What is Crinetics Pharmaceuticals annual net profit?
The current annual net income of CRNX is -$214.53 M
What is the all time high annual net income for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual net profit is -$6.02 M
What is Crinetics Pharmaceuticals quarterly net profit?
The current quarterly net income of CRNX is -$76.83 M
What is the all time high quarterly net income for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly net profit is -$1.65 M
What is Crinetics Pharmaceuticals quarterly net income year-on-year change?
Over the past year, CRNX quarterly net profit has changed by -$16.73 M (-27.84%)
What is Crinetics Pharmaceuticals TTM net profit?
The current TTM net income of CRNX is -$277.91 M
What is the all time high TTM net income for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM net profit is -$2.61 M
What is Crinetics Pharmaceuticals TTM net income year-on-year change?
Over the past year, CRNX TTM net profit has changed by -$63.38 M (-29.54%)